News
The fast-changing world of lower-limb atherectomy
Matching lesions with new devices, new approaches
News
No difference in serious infection rates between SLE treatments
News
Benralizumab reduces exacerbations in pivotal severe asthma trials
Key clinical point: Benralizumab significantly reduced the annual exacerbation rate (AER), improved lung function, and reduced asthma symptoms....
News
Durable Efficacy of Alemtuzumab: Five-Year Follow-Up of the CARE-MS Studies
LONDON—Autoimmune adverse events over five years were generally mild or moderate in intensity in alemtuzumab-treated patients...
News
Liraglutide cut risk of microvascular renal complications by 22% in type 2 diabetes; no eye benefit
Key clinical point: Liraglutide protected kidney function but conferred no benefit on microvascular eye complications in patients with type 2...
News
RPL-554 adds to short-acting drugs’ benefits in COPD
Key clinical point: RPL-554 added to short-acting reliever medications produced greater lung function benefits than did the monotherapies. Major...
News
Does the EDSS Capture Cognitive Difficulties in Patients With MS?
LONDON—The Expanded Disability Status Scale (EDSS) is largely insensitive to cognitive ability in patients with multiple...
Audio
AUDIO: New NIMH director discusses future of depression therapy
News
Aim for modulation with neurotoxin injections
BOSTON – When it comes to chemical denervation, it is best to aim for modulation rather than paralysis, according to Anthony Rossi, MD.
News
Cognitive-behavioral therapy eases postconcussive symptoms in teens
Teens with persistent postconcussive symptoms and depressive symptoms improved significantly after CBT was added to usual care.